Study shows consistent efficacy of Paxlovid regardless of age, number of vaccinations, comorbidities


In a recent study posted to the medRxiv* preprint server, researchers in Canada evaluated nirmatrelvir and ritonavir (Paxlovid) effectiveness against severe coronavirus disease 2019 (COVID-19) during the dominance of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Omicron variant of concern (VOC) and Omicron sub-VOCs in Canada.

Ready to shop? These are the best Walmart Black Friday deals you can buy right now.

Previous article

Study helps to justify the use of Ayres Sensory Integration as a tool for autistic children

Next article

You may also like


Leave a reply

Your email address will not be published. Required fields are marked *

More in News